65250-266 : Exparel 13.3 mg/ml Infiltration Injection, Suspension, Liposomal


NDC: 65250-266
Labeler: Pacira Pharmaceuticals Inc.
Product Type: Human Prescription Drug
Drug Name:  Exparel
Dosage Form: Infiltration Injection, Suspension, Liposomal
Application #: NDA022496
Rev. Date: 


NDC Package Codes:

  • 65250-266-04: 4 VIAL IN 1 CARTON (65250‑266‑04) > 20 ML IN 1 VIAL (65250‑266‑20)
  • 65250-266-09: 10 VIAL IN 1 CARTON (65250‑266‑09) > 20 ML IN 1 VIAL (65250‑266‑20)
  • 65250-266-20: 10 VIAL IN 1 CARTON (65250‑266‑20) > 20 ML IN 1 VIAL

Active Ingredients:

  • Bupivacaine

Dosage Strength:

  • 13.3 mg/mL

Pharmaceutical Classes:

  • Amide Local Anesthetic [EPC]
  • Amides [Chemical/Ingredient]
  • Local Anesthesia [PE]

Related Products:

Based on records with the same trade name.
  • 65250-133 Exparel 13.3 mg/ml Infiltration Injection, Suspension, Liposomal by Pacira Pharmaceuticals Inc.

NDC QR Code

Scan the QR code below to easily reference this data in the future:

NDC 65250-266 QR Code

< Prev: 65250-133Next: 65255-409 >

Related Discussions:

sterilisation of bupivacaine
Hello, I am in search of information on the stability of the bupivacaine sterilized with the gamma rays.Do you know if t...




Note: The RxChat NDC Database uses publicly available data from the FDA and the U.S. National Library of Medicine (NLM); The NLM is not responsible for the data presented and does not endorse or recommend this or any other product. While we make every effort to ensure that the information presented is accurate, you should assume that all results are unvalidated. To report any errors or inconsistencies please contact us.